KALV Competitors & Alternatives
Compare Kalvista Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
KALV
Main Stock$27.00
Tradestie Score
49
Market Cap
$608.81M
Revenue Growth
0.3%
Analyst Upside
+5.9%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$110.90
|
$1.55B | - | 42 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$38.77
|
$1.55B | 12.9 | 49 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$37.81
|
$1.55B | - | 44 | Compare |
|
NVAX
Novavax Inc
|
$8.66
|
$1.54B | - | 38 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.65
|
$1.50B | 7.6 | 40 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$48.34
|
$1.50B | - | 38 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$38.30
|
$1.49B | - | 41 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$30.71
|
$1.43B | - | 40 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$18.88
|
$1.42B | - | 39 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$19.75
|
$1.35B | - | 50 | Compare |
More KALV Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry